A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With Coronavirus Disease 2019 (COVID-19) Who Are Not Hospitalized But Are at Risk For Severe Disease
A Phase 3 study evaluating the efficacy and safety of ibuzatrelvir in non-hospitalized adults and adolescents with symptomatic COVID-19 who are at high risk of severe disease.